An interesting interview by Control Bionics (ASX:CBL) on the impact of their newly announced US insurance code which underpins what they believe will be a significant year for them in FY25. #asxnews $CBL #medtech #USHealthcare #NeuroNode #smallcap #investment
Our very own Jeremy Steele recently sat down with #AusbizTV to discuss the impact of our significant strategic milestone - US government approval for a new insurance code. This approval means our NeuroNode can now reach more people across the US, with coverage potential from Medicare, Medicaid, and even private insurance. It’s a significant step forward, ensuring that those who need our technology most can access it more easily. As Jeremy explained during the interview, getting a device approved for Medicare and Medicaid is no small feat—it’s a process that can take years. This is a huge achievement for Control Bionics, and we couldn't be more excited about the possibilities it opens up for the future! 🎥 Watch the full interview here https://lnkd.in/g3q8Kxaj #ControlBionics #MedTech #NeuroNode #Innovation #HealthcareTech #Medicare #Medicaid #AssistiveTechnology Roger Hawke Peter S Ford David Falk Lindsay Phillips Kerry Series Joe Durak Kanak Sahasrabudhe Adi Deshpande